Sativex Neuropathic Pain Uk

Cannabis - Wikipedia, The Free Encyclopedia
According to the UK medical journal The Lancet, AIDS wasting, neuropathic pain, treatment of spasticity associated with multiple sclerosis, and chemotherapy-induced nausea," the agency has not approved "medical marijuana". (Marinol) in many countries. The prescription drug Sativex, ... Read Article

East Lancashire Medicines Management Board
Neuropathic pain associated with multiple sclerosis. Locally,  Sativex has been available on a named-patient basis in the UK since December 2005. 48% with a 50% reduction in pain on Sativex v 12 with 50% reduction in pain on placebo. ... Read Content

SATIVEX® Fact Sheet - SDIS
(MHRA) in the UK has not approved Sativex® citing concerns of results not being neuropathic pain (such as TCA’s, anticonvulsants, analgesics or topical antineuralgics). Therefore, it is difficult to ascertain the efficacy of Sativex® compared to these alternative ... View Doc

Cannabidiol - Wikipedia, The Free Encyclopedia
A mouth spray for multiple sclerosis to alleviate pain. Sativex contains tetrahydrocannabinol together with cannabidiol. It is marketed in Canada by GW Pharmaceuticals. UK: Return to class B; USA: Decriminalization of non-medical cannabis. ... Read Article

General Principles Of Management Of Neuropathic Pain
Neuropathic Pain T Nurmikko MD PhD Professor of Pain Science Pain Research Institute & Division of Neurological Science, University of Liverpool The Walton Centre, Liverpool, UK www.painrelieffoundation.org.uk The Walton Centre for Neurology and Neurosurgery Cannabinoids –oromucosal Sativex on a ... Retrieve Document

Evidence Based Practice Group (EBPG) - WorkSafeBC.com - Home
Marinol OR sativex OR cesamet OR delta-9-tetrahydrocannabinol OR chronic neuropathic pain was published in October 2003 in JAMA(10). This article, the UK York University CRD, The UK National Institute for Clinical Excellence (NICE), ... View This Document

PowerPoint Presentation
Parallel group placebo controlled study of Sativex in central neuropathic pain in MS Single UK Centre Study N = 66 Treatment duration: parallel group placebo controlled study of Sativex in central neuropathic pain in MS Single UK Centre Study N = 66 Treatment duration: ... Fetch Full Source

Sativex Successfully Treats neuropathic pain Characterised By ...
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, a Division of Neurological Science, University of Liverpool, Liverpool, United Kingdom b Gartnavel General Hospital, Glasgow, United Kingdom c Solihull Hospital, Birmingham, United Kingdom ... Read Content

The Feasibility Study Of Sativex In China
Trials in MS Spasticity and Neuropathic Pain has been obtained. 1 GW EU Regulatory Withdrawal; Jul 20th 2007; from GW Pharmaceuticals website; the cooperation from the UK partner; sales experience of Sativex’s competitive ... Fetch Document

AUTHORIZATION WITH CONDITIONS OF (Tetranabinex And Nabidiolex ...
Scale pain scores on SATIVEX • as adjunctive treatment for the symptomatic relief of neuropathic pain in multiple sclerosis in adults. Contraindications Wiltshire UK, SP4 0JQ Bayer Inc. 77 Belfield Road Toronto, Ontario M9W 1G6 ... Return Document

PRESCRIBING And CLINICAL EFFECTIVENESS NEWSLETTER Supporting ...
Peter.burrill@derbyshirecountypct.nhs.uk PRESCRIBING and CLINICAL EFFECTIVENESS NEWSLETTER Volume 9: Issue 5 August 2010 Further in this issue Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Neuropathic pain guideline Sativex oral spray Glusartel oral powder More bad news for rosiglitazone ... Fetch Here

Sativex Fact Sheet V2 - MS Info, Research, News And Support ...
Effectiveness of Sativex in treating neuropathic pain. How is it administered? Sativex was approved for the treatment of spasticity in people with MS in the UK and in Spain in 2010. Sativex has not been considered by the National Institutes for Health and Clinical ... Access Content

Tetrahydrocannabinol - Wikipedia, The Free Encyclopedia
Who can use it to alleviate neuropathic pain and spasticity. Sativex contains tetrahydrocannabinol together with cannabidiol and is a preparation of whole cannabis rather than individual cannabinoids. ^ "Sativex Oromucosal Spray". medicines.org.uk. 2011-06-09. ... Read Article

Efficacy Of Two Cannabis Based Medicinal Extracts For Relief ...
Licensed in the United Kingdom as an antiemetic during (Sativexw) and a THC extract, coded as GW-2000-02. The in central neuropathic pain are now required to demonstrate a clinically relevant, improvement in the treatment of this ... Read Here

Canada Sativex MS Spasticity NOC - Final Aug31
Health Canada Grants Full Approval of Sativex  For the Treatment of Spasticity Due to Multiple Sclerosis Porton Down, UK; Toronto, Canada – August 31, 2010 – GW Pharmaceuticals plc neuropathic pain in adult patients with multiple sclerosis, ... Read Here

Cannabinoids In Cancer pain - Cannabis Medicine
Inflammatory or neuropathic pain. This may explain the differences of cannabinoid effects in acute and Sativex (GW Pharmaceu-ticals, UK) contains dronabinol and cannabidiol in a ratio of about 1:1 and is administered as a spray into the mouth (oromucosal use). The pharmacokinetic ... Access Full Source

Chemical In Marijuana To Slow Multiple Sclerosis?
In April 2005, GW announced that it had received approval to distribute Sativex in Canada for the symptomatic relief of neuropathic pain in adults with Multiple Sclerosis.24. and GW Pharmaceuticals in the UK, USA and Canada produce Sativex®, a cannabinoid-based drug. ... Read Article

4:20 Interview With Pete Hodgson MP (Minister Of Health 2005 ...
Sativex is a mouth spray developed by the UK company GW Pharmaceuticals for multiple sclerosis patients, who can use it to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. ... View Video

Pain - MS Trust | Multiple Sclerosis Trust
Neuropathic pain is caused by disruption in how the nerves carry messages based drug Sativex is licensed for use as an add-on treatment for spasticity The representative body for professionals involved in the management of pain in the UK. ... View Document

Preliminary Assessment Of The Efficacy, Tolerability And ...
KEY WORDS: Cannabis-based medicine, Sativex, Pain, Rheumatoid arthritis activity in both nociceptive and neuropathic pain [1, 2 Northampton General Hospital, Northampton and 3Department of Rheumatology, Selly Oak Hospital, Birmingham, UK. Received 6 July 2005; revised version ... Access Content

Sativex® Oromucosal Spray - South Staffordshire Primary Care ...
MS and is investigating Sativex’s effects on neuropathic pain, the results are expected mid 2008. on Sativex Oromucosal Spray UK/H/961/01/DC . Title: Microsoft Word - M&P - PPS - Sativex Guidance SSPCT _Apr08_.doc Author: Phillip.Steventon ... Visit Document

Sativex 1110 Updated1212 - MS Trust | Multiple Sclerosis Trust
UK charity which works to improve the lives of people affected by MS. We rely Sativex was the first cannabis-based medicine to be licensed in the UK. It is neuropathic pain, including in MS. 13. ... Retrieve Here

pain Brochure 2011 - ASA : Advancing Legal Medical Marijuana ...
Spain, New Zealand, and the UK for Sativex® Oromucosal Spray, a con-trolled-dose whole-plant extract. Sativex® was approved in Canada for symptomatic relief of neuropathic pain in 2005, in 2007 for patients with advanced cancer whose pain is not fully alleviated by opiods, and in 2010 ... Access This Document

Nice Neuropathic Pain March 2010

Coping With Chronic Nerve Pain -- Chronic Neuropathic Pain Coping
Updated March 11, 2010. Try listening to some peaceful music, soaking in a warm bath or taking a nice stroll. Coping With Chronic Nerve Pain – When You Need More Help. Neuropathic Pain: Working With Your Provider. Accessed 2/18/10. ... Read Article

Delphi Study WHO Pain Guidelines
Neuropathic pain (including nerve compression pain, post-nerve injury and post-amputation pain, diabetic neuropathy, 28 March, 2007 The guidelines provided in WHO publication from Department of VIP Guidelines for Essential Trauma ... Read Full Source

GUIDANCE FROM THE MEDICINES MANAGEMENT GROUP FOR PRESCRIBING ...
These guidelines will need to be updated as and when amended NICE Guidelines Date: December 2010 Version 1.5 Ratified: 31st March 2011 Review: st31 March 2013 Author: Joan Miller . 2 of 3 Indications Generalised anxiety disorder (GAD) in adults. (Also licensed for neuropathic pain and ... Visit Document

Aa CV Engl Feb2011 - Www.skinbiopsy.org
− 10 th Course on Therapeutic Frontiers in Neurology, Bergamo, March 13, 2010 - Neuroprotection of Peripheral Nerves Nice June 7, 2008 Lauria G. Neuropathic pain and diabetes: focus on mechanisms and potential therapeutic strategies. ... Get Document

Sativex Fact Sheet V2 - MS Info, Research, News And Support ...
Effectiveness of Sativex in treating neuropathic pain. How is it administered? In March 2009 GW Pharmaceuticals announced results of two clinical trials involving Sativex (NICE) which means that decisions to fund Sativex will be made at a local level. ... Access Document

ODS HEALTH PLANS - ODS Companies ??? Provider Of Group And ...
Pain. March 1996; 12(1):43 -49 .  Dyer MT, Goldsmith K, Khan S, Sharples L, (NICE). Pain (chronic neuropathic or ischaemic) - Pain Med. 2010;11(5):685 -691.  Taylor RS, De Vries J, Buchser E, Dejongste MJ. ... View Doc

The Pink One
75% to 89% at the end of March. In ward 4A (surgical admissions), compli- the management of neuropathic pain. This article clarifies the position of NICE advice in NHS Scotland. NICE, neuropathic pain and pregabalin: not for implementation ... Doc Viewer

Volume 5; Number 5 March 2011
Volume 5; Number 5 March 2011  The shared care guideline on the use of nabilone for chronic neuropathic pain has been reviewed and updated (see page 10). (August 2010) Page 7 NICE Technology Appraisal 210: Clopidogrel and modified release ... Get Content Here

2010-2013 Major depressive disorder, Generalized Anxiety disorder, neuropathic pain, urinary incontinence Dopamine reuptake inhibitors bupropion http://guidance.nice.org.uk/CG23. Accessed: March 5, 2008. . Page 4 of 4 © 2008. RegenceRx. All rights ... Retrieve Here

PRESCRIBING &
In March NICE reissued clinical guideline 67, be made by preventing over-investigation through vetting and reviewing requests and stopping radiography for lower back pain as per NICE guidance”. 1. BMJ 2010; Gabapentin reduces neuropathic pain by <1 point on a 0 ... Return Doc

Talk:Gabapentin - Wikipedia, The Free Encyclopedia
Would whoever made the nice ball-and-stick structure please redo it with either the zwitterionic or H Gabapentin is typically used in neuropathic pain (pain due to compression or damage to nerves). Nevertheless: good to hear, and I hope the benefits Tn pain 04:37, 12 March 2008 (UTC) ... Read Article

BExlEy TREATMENT GUIDElINES
Of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PhN). For further information please refer to March 2010 NICE guideline CG96, Neuropathic pain: the pharmacological management of neuropathic pain in ... Get Doc

Peripheral Neuropathy - Wikipedia, The Free Encyclopedia
A great deal of research has been done between 2005 and 2010 which indicates that synthetic cannabinoids and inhaled cannabis are effective treatments for a range of neuropathic disorders. is also being used to reduce neuropathic pain. ... Read Article

Aa CV Engl Apr2011 - Www.skinbiopsy.org
− 10 th Course on Therapeutic Frontiers in Neurology, Bergamo, March 13, 2010 - Neuroprotection of Peripheral Nerves Nice June 7, 2008 Lauria G. Neuropathic pain and diabetes: focus on mechanisms and potential therapeutic strategies. ... Get Doc

Section 2 General PROMOTING ACTION ON CLINICAL EFFECTIVENESS ...
Section 5 Management of Neuropathic Pain and NICE Diabetes in Pregnancy CG63. March 2008 • Preconceptual diabetes care – PACE event presentation be offered a care plan by 2010. Care Planning Consultations versus Care Plans ... Access This Document

NHS North Central London Policy
Spinal cord stimulation for chronic pain of neuropathic or ischemic origin. NICE Technology Assessment Guidance 159, (2010) Journal of Plastic, Reconstructive and March 2000 http://www.nice.org.uk/guidance/TA1 2. ‘Management of Unerupted and Impacted Third Molar Teeth ... Access Doc

PoLCE: Consolidation Of Evidence Base FINAL
Et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007;14(9):952-70. NICE - Pain (chronic neuropathic or ischaemic) National Institute for Clinical Excellence, 2001. NICE Interventional Procedures guidance (accessed March 2010) ONEL. SWL . ONEL. SWL ... Document Retrieval

Keeping A Pain Journal - About Chronic Pain - Symptoms ...
Very nice article on pain. Thanks for the great tips! March 9, 2010 at 9:07 pm (3) ankle pain says: i keep a pain journal Coping With Chronic Nerve Pain -- Chronic Neuropathic Pain Coping; Pain Journal - What's In Your Pain Journal; ... Read Article

YouTube
Unfortunately opiods like morphine dont work for neuropathic pain like Trigeminal Neuralgia : Symptom in late summer 2010, about 2 months. My Dr. did a cat scan, sent me to see It just began again in March 2012, I'm looking for anything other than meds. Please let us know if you got the ... View Video

Traffic Light Drugs May 2000 - NHS Sheffield - Sheffield's ...
20 March 2012 . BNF . Section . Drug . Rationale Key: see appendix Notes BLACK ; 2.8.2 : (September 2010) See: NICE CG 20. Newer Drugs for Epilepsy in Children TA79. Epilepsy (Adults) Pain/Neurology & Neuropathic pain . 1.6.7 . Prucalopride : 1, 2 . See . prescribing guidance. ... Return Document

2004-2010 Update
Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant and joint decade 2000-2010 Task force on neck pain and its associated disorders. Hogg-Johnson, summary of NICE guidelines. Conaghan, P ... Access Doc

Policy
W.P., (2010). Spinal Cord Stimulation. Retrieved from http://solutionsforpain.net Pain of Neuropathic or Ischemic Origin. NICE: National Institute Last Accessed July 6, 2011 6. Hayes, Inc., Medical Technology Directory, (2009, March 9). Spinal Cord Stimulation for Relief of ... Content Retrieval

Cb1 Neuropathic Pain

FAAH Inhibitors And Their Complications; Value Of ...
Endocannabinoids (eCBs) are endogenous agonists of cannabinoid CB1 and CB2 receptors, a natural compound for treating neuropathic pain by chronicpaincoalition 306 views; 1:38 Lyrica and palmitoylethanolamide (Normast) in refractory pain patients by chronicpaincoalition 97 views; ... View Video

Current Pain Pharmacotherapy
Neuropathic pain • Lacosamide is new and novel, and supported by RCT in DPN (Ziegler D, et al. Diabetes Care2010;33:839-41) NMDA-Receptor Antagonists • NMDA receptor involved in neuropathic pain and opioid tolerance efficacy of both CB1 and CB2 agonists ... View Document

Chapter 1
Produced by Bayer and GW pharmaceuticals and approved for use in Canada for multiple sclerosis and neuropathic pain cannibinoid reduce intestinal motility and secretions cannibinoids reduce inflammation CB1 knockouts or CB1 blockade enhances inflammation CB1 receptors may ... Document Viewer

Putting The Medical In Medical Marijuana - Back Pain And Neck ...
Smoking a joint socially generally results in activation of a CB1 (type 1) receptor in the body. When activated the CB1 receptor yields psychoactive effects - in other words, you get high. therefore reducing the likelihood of neuropathic pain." ... Read Article

Cannabinoids As Pharmacotherapies For Neuropathic Pain: From ...
Neuropathic pain is often refractory to conventional pharma-cotherapies, necessitating validation of novel analgesics. Can- noid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol 2007;152:765–777. ... Fetch Here

Efficacy Of Two Cannabis Based Medicinal Extracts For Relief ...
CB1 receptor, which is found at many sites within the central nervous system (Pertwee, 2001). in central neuropathic pain are now required to demonstrate a clinically relevant, improvement in the treatment of this condition. Acknowledgements ... Read Here

Cannabis In Pain And Palliative Care 10
Phenotype of CB1 Knockout Mice • Increased anxiety, increased susceptibility to the depressive effects of chronic stress Martin et al. models of neuropathic pain Supported in part by UC CMCR and NIH GCRC funds. Objectives of Neuropathy Trial ... Read Full Source

Pain Therapeutics - Acnr | Advances In Clinical Neuroscience ...
NEUROPATHIC PAIN Endocannabinoids, cannabinoid agonists and neuropathic pain • Cannabinoid agonists • CB1 and CB2 receptors • Endocannabinoids • FAAH inhibitors • Future prospects Aldemar Degroot, Scientist, Exploratory Development Department, Astellas ... Access This Document

The Role Of Cannabinoids & The Endocannabinoid System In Pain ...
Neuropathic pain is a chronic pain syndrome associated with drug, injury or disease-induced destruction of sensory afferent fibers of the dorsal root ganglia (DRG) presynaptic CB1 receptors, similar to endocannabinoids ... Read Document

The Medical Use Of Cannabinoids For Chronic pain
–CB1, CB2, TRPV1, PPAR, 5-HT, shown to relieve peripheral neuropathic pain, but the effect size is small, and there was no effect in a small study in painful poly-neuropathy. Smoked cannabis has been shown to be superior to ... Visit Document

Neuropathic pain
Neuropathic pain Unmet needs for patients demands Ayman Abd Al-Maksoud Yousef, MD Lecturer of Anesthesiology and Pain Relief, Faculty of Medicine, CB1 and CB2. The efficacy of cannabinoids towards pain modulation is mediated mainly through CB1 ... Access Doc

Cannabinoids And Pain - Dalhousie Pharmacology
Efficacy In models of chronic pain cannabinoids exhibit even greater potency and efficacy in models of inflammatory and neuropathic pain Electrophysiological studies of nociceptive Applications Pain as an example Location of CB1 receptors of importance to pain related ... Access Content

Nabilone - Wikipedia, The Free Encyclopedia
Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. perhaps downregulating the CB1 system can help remove the highly potentiated, hippocampal/amydygalia memories of the fear. At the very least, ... Read Article

INTERNATIONAL CANNABINOID RESEARCH SOCIETY
!OF!CB1!RECEPTORS! 21 8.45 Maria!Grazia!Cascio,! Daniele!Bolognini!! and!Roger!G.!Pertwee! THECB1!RECEPTOR!ALLOSTERIC! TREATMENTOF!NEUROPATHIC!PAIN! 39 15.45 James!Burston,!! Devi!Sagar,!Stephen! Woodhams,!Gareth! Hathway,!Emma!King,!!!!! Andrew!Bennett,!! David ... Return Document

Smoked Medicinal Cannabis For Neuropathic Pain In HIV: A ...
The endogenous ligand of CB1, anandamide, itself is an effective antinociceptive agent (Calignano, et al., 1998). neuropathic pain associated with multiple sclerosis indicated that both sublingual delta-9-THC alone or with cannabidiol (Rog, et al., ... Fetch This Document

Sativex Successfully Treats neuropathic pain Characterised By ...
In Neuropathic Pain Scale composite score (p = 0.007), sleep NRS (p = 0.001), dynamic allodynia (p = 0.042), punctate allodynia receptors, CB1 and CB2. CB1 is widely distributed in the peripheral and central nervous system, acting as a ... Fetch Doc

Smoked Medicinal Cannabis For Neuropathic Pain In HIV: A ...
Ligand of CB1, anandamide, itself is an effective antinoci-ceptive agent (Calignano et al, 1998). In open-label clinical neuropathic pain intensity in HIV-associated DSPN com-pared to placebo, when added to stable concomitant analgesics. ... Access Document

Pain And Disability - StopPain.org, Department Of Pain ...
Efficacy of both CB1 and CB2 agonists diabetic neuropathic pain (Wymer et al, Clin J Pain, 25:376, 2009) Sodium Channel Blockers Side effects of conventional oral drugs common and usually considered for neuropathic pain after other drugs fail ... Doc Retrieval

Cannabis-opioids And neuropathic pain - YouTube
From www.neuropathy.nl an explanation by prof.dr. Jan M. Keppel Hesselink from the institute for neuropathic pain. Opioid and cannabinoid receptors are expressed in our brain and our peripheral nervous system, CB1 (and CB2) receptors are even ... View Video

Cancer Pain Management - The British Pain Society - Home Page
• GABAA receptors and possibly also CB1 receptors reduce neuronal excitability, which can be exploited therapeutically by benzodiazepines, neuropathic pain diagnoses were treated with opioids (morphine 52%) and a range of adjuvants (amitriptyline 30%, gabapentin 30%, gabapentin and ... Get Content Here

Glenmark's Molecule For neuropathic pain, Osteoarthritis ...
GRC 10693 has >4700-fold functional selectivity for CB2 over CB1 making it one of the most selective CB2 agonist reported in development. Speaking on this development, Mr. Glenn Saldanha, MD & CEO, Glenmark neuropathic pain market is estimated at around USD 5 billion with over 40 million ... View This Document

Case Study: Management Of Post- Parotidectomy Neuropathic ...
A central mechanism of cannabinoid pain suppression show evidence of CB1 receptor afferents originating supraspinally and anti neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007 Spring;12(1):13-21. ... Document Retrieval

The Oral Pharmacotherapy Of Peripheral Neuropathic Pain
1988 CB1 (10x number vs. mu opioid receptors) All pharmacotherapeutic approaches to neuropathic pain have at best a modest effect ... Fetch Content

GW-405,833 - Wikipedia, The Free Encyclopedia
Selective CB 2 agonist drugs such as GW-405,833 are hoped to be particularly useful in the treatment of allodynia and neuropathic pain for which current treatment options are often inadequate. References Cannabinoids ... Read Article

Anorexia/Cachexia, Fatigue, Depression And Advanced Pain ...
ς

Dray 2008 Neuropathic Pain Emerging Treatments

Lacosamide - Wikipedia
Lacosamide (merknaam: Vimpat van UCB) is een anti-epileptisch geneesmiddel . De Europese Commissie vergunde het middel in de Europese Unie op 29 augustus 2008 . In de Verenigde Staten werd het middel in juni 2009 gelanceerd. Lacosamide werd in de jaren 1990 gesynthetiseerd door de Amerikaanse ... Read Article

Curriculum Vitae - Johns Hopkins University - Department Of ...
Emerging Strategies for the Treatment of Neuropathic Pain, J.N. Campbell, A.I. Basbaum, A. Dray, R. Dubner, R.H. Dworkin and C.N. Sang (Eds) IASP Press, advisor on potential targets for neuropathic pain therapies. 2008 Biogen-Idec, ... Read More

Suffolk Drug & Therapeutics Group
Prescriber/Pharmacy Statement – December 2008, GW Pharmaceuticals. Freynhagen R & Bennett MI. Diagnosis and management of neuropathic pain. British Medical Journal 2009; 339: 391-5. Dray A. Neuropathic pain: emerging treatments. British Journal of Anaesthesia 2008; 101 (1): 48-58. ... View Doc

Sauna - Wikipedia, The Free Encyclopedia
Very often massage and other body and skin treatments are available at the same facilities, either by themselves or in the customer's private room. It is indicated for rheumatic pain (with cold shower) but not for neuropathic pain. Is effective for appetite loss and mild depression. ... Read Article

BooksBooks Available
Treating neuropathic pain and to researchers studying this difficult but important problem. J.N. Campbell, A.I. Basbaum, A. Dray, R. Dubner, R.H. Dworkin, C.N. Sang (Eds). 2006, hardbound volume speaks to core issues integral to emerging pain research and humane health care in the 21st century. ... Doc Viewer

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain in response to fungal pathogens and hormone treatments a systematic review of evidence (1996-2008) ... Content Retrieval